Cargando…
Non-invasive intranasal administration route directly to the brain using dendrimer nanoplatforms: An opportunity to develop new CNS drugs
There are several routes of administration to the brain, including intraparenchymal, intraventricular, and subarachnoid injections. The blood-brain barrier (BBB) impedes the permeation and access of most drugs to the central nervous system (CNS), and consequently, many neurological diseases remain u...
Autores principales: | Mignani, Serge, Shi, Xiangyang, Karpus, Andrii, Majoral, Jean-Pierre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Masson SAS.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548078/ https://www.ncbi.nlm.nih.gov/pubmed/33069435 http://dx.doi.org/10.1016/j.ejmech.2020.112905 |
Ejemplares similares
-
Functionalized Dendrimer Platforms as a New Forefront Arsenal Targeting SARS-CoV-2: An Opportunity
por: Mignani, Serge, et al.
Publicado: (2021) -
Engineered phosphorus dendrimers as powerful non-viral nanoplatforms for gene delivery: a great hope for the future of cancer therapeutics
por: Mignani, Serge, et al.
Publicado: (2022) -
Engineered Neutral Phosphorous Dendrimers Protect Mouse Cortical Neurons and Brain Organoids from Excitotoxic Death
por: Posadas, Inmaculada, et al.
Publicado: (2022) -
New Ways to Treat Tuberculosis Using Dendrimers as Nanocarriers
por: Mignani, Serge, et al.
Publicado: (2018) -
Dendrimer– and polymeric nanoparticle–aptamer bioconjugates as nonviral delivery systems: a new approach in medicine
por: Mignani, Serge, et al.
Publicado: (2020)